Update of Guidelines for Laboratory Diagnosis of COVID-19 in Korea

키워드

참고문헌 (82)

1. Ki Ho Hong, "Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea", Annals of Laboratory Medicine, 40(5), pp.351~360 (2020), 대한진단검사의학회[DOI]
2. Kevadiya BD, "Diagnostics for SARS-CoV-2 infections", Nat Mater, 20, pp.593~605 (2021)
3. Au WY, "Diagnostic performances of common nucleic acid tests for SARS-CoV-2 in hospitals and clinics : a systematic review and meta-analysis", Lancet Microbe, 2, pp.e704~e714 (2021)
4. Freije CA, "Detect and destroy : CRISPR-based technologies for the response against viruses", Cell Host Microbe, 29, pp.689~703 (2021)
5. Subali AD, "Reverse transcriptase loop mediated isothermal amplification(RT-LAMP)for COVID-19 diagnosis : a systematic review and meta-analysis", Pathog Glob Health, 115, pp.281~291 (2021)
6. Subsoontorn P, "The diagnostic accuracy of isothermal nucleic acid point-of-care tests for human coronaviruses: a systematic review and meta-analysis", Sci Rep, 10, pp.22349~ (2020)
7. Thwe PM, "Abbott ID now COVID-19 assay performance : a year in review", Diagn Microbiol Infect Dis, 101, pp.115536~ (2021)
8. Mohammadi A, "SARS-CoV-2 detection in different respiratory sites : a systematic review and meta-analysis", EBiomedicine, 59, pp.102903~ (2020)
9. Pastorino B, "Evaluation of chemical protocols for inactivating SARS-CoV-2 infectious samples", Viruses, 12, pp.624~ (2020)
10. Welch SR, "Analysis of inactivation of SARS-CoV-2 by specimen transport media, nucleic acid extraction reagents, detergents, and fixatives", J Clin Microbiol, 58, pp.e01713-20~ (2020)
11. Harrison C, "A systematic review and meta-analysis of upper airway swab collection for detection of viral and bacterial pathogens by individuals or caregivers compared to health care workers", J Clin Microbiol, 59, pp.e0230420~ (2021)
12. Lee RA, "Performance of saliva, oropharyngeal swabs, and nasal swabs for SARS-CoV-2 molecular detection : a systematic review and meta-analysis", J Clin Microbiol, 59, pp.e02881-20~ (2021)
13. Butler-Laporte G, "Comparison of saliva and nasopharyngeal swab nucleic acid amplification testing for detection of SARS-CoV-2 : a systematic review and meta-analysis", JAMA Intern Med, 181, pp.353~360 (2021)
14. Bastos ML, "The sensitivity and costs of testing for SARS-CoV-2 infection with saliva versus nasopharyngeal swabs : a systematic review and meta-analysis", Ann Intern Med, 174, pp.501~510 (2021)
15. Nacher M, "Prospective comparison of saliva and nasopharyngeal swab sampling for mass screening for COVID-19", Front Med(Lausanne), 8, pp.621160~ (2021)
16. Nagura-Ikeda M, "Clinical evaluation of self-collected saliva by quantitative reverse transcription-PCR(RT-qPCR), direct RT-qPCR, reverse transcription-loop-mediated isothermal amplification, and a rapid antigen test to diagnose COVID-19", J Clin Microbiol, 58, pp.e01438-20~ (2020)
17. Marx GE, "Detection of severe acute respiratory syndrome coronavirus 2on self-collected saliva or anterior nasal specimens compared with healthcare personnel-collected nasopharyngeal specimens", Clin Infect Dis, 73(S1), pp.S65~S73 (2021)
18. Smith-Jeffcoat SE, "Effects of patient characteristics on diagnostic performance of self-collected samples for SARS-CoV-2 testing", Emerg Infect Dis, 27, pp.2081~2089 (2021)
19. Congrave-Wilson Z, "Change in saliva RT-PCR sensitivity over the course of SARS-CoV-2 infection", JAMA, 326, pp.1065~1067 (2021)
20. Migueres M, "Testing individual and pooled saliva samples for sars-cov-2 nucleic acid : a prospective study", Diagn Microbiol Infect Dis, 101, pp.115478~ (2021)
21. Barat B, "Pooled saliva specimens for SARS-CoV-2 testing", J Clin Microbiol, 59, pp.e02486-20~ (2021)
22. Ho YI, "Comparison of three commercial SARS-CoV-2 assays for pooled testing of deep throat saliva for surveillance of patients attending general outpatient clinics", J Med Virol, 93, pp.1917~1919 (2021)
23. McMillen T, "Evaluation of sample pooling for SARS-CoV-2 RNA detection in nasopharyngeal swabs and salivas on the Roche Cobas 6800", J Clin Virol, 138, pp.104790~ (2021)
24. Hanson KE, "Infectious Diseases Society of America guidelines on the diagnosis of COVID-19", Clin Infect Dis, pp.ciaa67~ (2021)
25. Hanson KE, "The Infectious Diseases Society of America guidelines on the diagnosis of COVID-19 : molecular diagnostic testing", Clin Infect Dis, pp.ciab048~ (2021)
26. "SARS-CoV-2 viral mutations: impact on COVID-19 tests" (2021)[URL]
27. Artesi M, "A recurrent mutation at position 26340 of SARS-CoV-2 is associated with failure of the E gene quantitative reverse transcription-PCR utilized in a commercial dual-target diagnostic assay", J Clin Microbiol, 58, pp.e01598-20~ (2020)
28. Ziegler K, "SARS-CoV-2 samples may escape detection because of a single point mutation in the N gene", Euro Surveill, 25, pp.2001650~ (2020)
29. Hong Ki Ho, "Prevalence of a Single-Nucleotide Variant of SARS-CoV-2 in Korea and Its Impact on the Diagnostic Sensitivity of the Xpert Xpress SARS-CoV-2 Assay", Annals of Laboratory Medicine, 42(1), pp.96~99 (2022), 대한진단검사의학회[DOI]
30. Vanaerschot M, "Identification of a polymorphism in the N gene of SARS-CoV-2 that adversely impacts detection by reverse transcription-PCR", J Clin Microbiol, 59, pp.e02369-20~ (2020)
31. Rhoads DD, "Endemic SARS-CoV-2 polymorphisms can cause a higher diagnostic target failure rate than estimated by aggregate global sequencing data", J Clin Microbiol, 59, pp.e0091321~ (2021)
32. Khoshchehreh M, "A needle in the haystack? Assessing the significance of envelope (E) gene-negative, nucleocapsid (N2) gene-positive SARS-CoV-2 detection by the Cepheid Xpert Xpress SARS-COV-2 assay", J Clin Virol, 133, pp.104683~ (2020)
33. Tahan S, "SARS-CoV-2 E gene variant alters analytical sensitivity characteristics of viral detection using a commercial reverse transcription-PCR assay", J Clin Microbiol, 59, pp.e0007521~ (2021)
34. Bal A, "Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012", 01 and other variants with spike deletion H69-V70, France, August to December 2020, 2021, pp.26, 2100008~
35. Borges V, "Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021", Euro Surveill, 26, pp.2100131~ (2021)
36. Huggett JF, "Cautionary note on contamination of reagents used for molecular detection of SARS-CoV-2", Clin Chem, 66, pp.1369~1372 (2020)
37. Rosebrock AP, "DNA cross-reactivity of the CDC-specified SARS-CoV-2 specimen control leads to potential for false negatives and underreporting of viral infection", Clin Chem, 67, pp.435~437 (2021)
38. Braunstein GD, "False positive results with SARS-CoV-2 RT-PCR tests and how to evaluate a RT-PCR-positive test for the possibility of a false positive result", J Occup Environ Med, 63, pp.e159~e162 (2021)
39. Heungsup Sung, "COVID-19 Molecular Testing in Korea: Practical Essentials and Answers From Experts Based on Experiences of Emergency Use Authorization Assays", Annals of Laboratory Medicine, 40(6), pp.439~447 (2020), 대한진단검사의학회[DOI]
40. Zhang YV, "AACC practical recommendations for implementing and interpreting SARS-CoV-2 EUA and LDT serologic testing in clinical laboratories", Clin Chem, 67, pp.1188~1200 (2021)
41. "IDSA and AMP joint statement on the use of SARS-CoV-2 PCR cycle threshold (Ct) values for clinical decision-making 2021" (2021)[URL]
42. "AACC Recommendation for reporting SARS-CoV-2 cycle threshold (CT) values 2021" (2021)[URL]
43. Evans D, "The dangers of using Cq to quantify nucleic acid in biological samples : a lesson from COVID-19", Clin Chem, 68, pp.153~162 (2021)
44. Buchta C, "Variability of cycle threshold values in an external quality assessment scheme for detection of the SARS-CoV-2 virus genome by RT-PCR", Clin Chem Lab Med, 59, pp.987~994 (2021)
45. Fischer C, "Variable sensitivity of SARS-CoV-2 molecular detection in European expert laboratories : external quality assessment, June and July 2020", J Clin Microbiol, 59, pp.e02676-20~ (2021)
46. Sung H, "Nationwide external quality assessment of SARS-CoV-2 molecular testing, South Korea", Emerg Infect Dis, 26, pp.2353~2360 (2020)
47. Matheeussen V, "International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April", May 2020, 2020, pp.25, 2001223~
48. Binnicker MJ, "Challenges and controversies to testing for COVID-19", J Clin Microbiol, 58, pp.e01695-20~ (2020)
49. Binnicker MJ, "Can testing predict SARS-CoV-2 infectivity? The potential for certain methods to be surrogates for replication-competent virus", J Clin Microbiol, 59, pp.e0046921~ (2021)
50. Kim SY, "Pooling upper respiratory specimens for rapid mass screening of COVID-19 by real-time RT-PCR", Emerg Infect Dis, 26, pp.2469~2472 (2020)
51. Yelin I, "Evaluation of COVID-19 RT-qPCR test in multi sample pools", Clin Infect Dis, 71, pp.2073~2078 (2020)
52. Lippi G, "Upper respiratory samples pooling for screening SARS-CoV-2 infection : ready for the prime time", Clin Chem Lab Med, 58, pp.e307~e309 (2020)
53. Lee J, "Challenges and issues of SARS-CoV-2 pool testing", Lancet Infect Dis, 20, pp.1232~1233 (2020)
54. Wang H, "Performance of nucleic acid amplification tests for detection of severe acute respiratory syndrome coronavirus 2 in prospectively pooled specimens", Emerg Infect Dis, 27, pp.92~103 (2021)
55. Garg A, "Evaluation of seven commercial RT-PCR kits for COVID-19 testing in pooled clinical specimens", J Med Virol, 93, pp.2281~2286 (2021)
56. Lee Jaehyeon, "Clinical Performance of the Standard Q COVID-19 Rapid Antigen Test and Simulation of its Real-World Application in Korea", Annals of Laboratory Medicine, 41(6), pp.588~592 (2021), 대한진단검사의학회[DOI]
57. Bohn MK, "IFCC interim guidelines on molecular testing of SARS-CoV-2 infection", Clin Chem Lab Med, 58, pp.1993~2000 (2020)
58. Dinnes J, "Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection", Cochrane Database Syst Rev, 3, pp.CD013705~ (2021)
59. Hanson KE, "The Infectious Diseases Society of America guidelines on the diagnosis of COVID-19 : antigen testing", Clin Infect Dis, pp.ciab557~ (2021)
60. "Options for the Use of Rapid Antigen Tests for COVID-19 in the EU/EEA and the UK-first update" (2021)[URL]
61. Pray IW, "Performance of an antigen-based test for asymptomatic and symptomatic SARS-CoV-2 testing at two university campuses—Wisconsin, September–October 2020", MMWR Morb Mortal Wkly Rep, 69, pp.1642~1647 (2021)
62. Oh Sang-Min, "Clinical Application of the Standard Q COVID-19 Ag Test for the Detection of SARS-CoV-2 Infection", Journal of Korean Medical Science, 36(14), pp.1~5 (2021), 대한의학회[DOI]
63. Brihn A, "Diagnostic performance of an antigen test with RT-PCR for the detection of SARS-CoV-2 in a hospital setting—Los Angeles County, California, June–August 2020", MMWR Morb Mortal Wkly Rep, 70, pp.702~706 (2021)
64. Ferguson J, "Validation testing to determine the sensitivity of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings : testing frequency and public health messaging is key", PLoS Biol, 19, pp.e3001216~ (2021)
65. Tinker SC, "Point-of-care antigen test for SARS-CoV-2 in asymptomatic college students", Emerg Infect Dis, 27, pp.2662~2665 (2021)
66. García-Fiñana M, "Performance of the Innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot : population based cohort study", BMJ, 374, pp.n1637~ (2021)
67. Ford L, "Epidemiologic characteristics associated with severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)antigen-based test results, real-time reverse transcription polymerase chain reaction(rRT-PCR)cycle threshold values, subgenomic RNA, and viral culture Results from university testing", Clin Infect Dis, 73, pp.e1348~e1355 (2021)
68. Blairon L, "Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods : experiences of a general hospital", J Clin Virol, 129, pp.104472~ (2020)
69. Whitman JD, "Evaluation of SARS-CoV-2 serology assays reveals a range of test performance", Nat Biotechnol, 38, pp.1174~1183 (2020)
70. Ong DSY, "How to interpret and use COVID-19 serology and immunology tests", Clin Microbiol Infect, 27, pp.981~986 (2021)
71. Theel ES, "The role of antibody testing for SARS-CoV-2 : is there one", J Clin Microbiol, 58, pp.e00797-20~ (2020)
72. "Antibody testing is not currently recommended to assess immunity after COVID-19 vaccination: FDA safety communication" (2021)[URL]
73. "Interim guidelines for COVID-19 antibody testing" (2022)[URL]
74. "Notice on airline boarding requirements for certificates of negative nucleic acid and anti-body blood tests results" (2020)[URL]
75. Hanson KE, "Infectious Diseases Society of America guidelines on the diagnosis of COVID-19 : serologic testing", Clin Infect Dis (2020)
76. Park Younhee, "Performance Comparison of Five SARS-CoV-2 Antibody Assays for Seroprevalence Studies", Annals of Laboratory Medicine, 42(1), pp.71~78 (2022), 대한진단검사의학회[DOI]
77. Yun Sojeong, "Comparison of SARS-CoV-2 Antibody Responses and Seroconversion in COVID-19 Patients Using Twelve Commercial Immunoassays", Annals of Laboratory Medicine, 41(6), pp.577~587 (2021), 대한진단검사의학회[DOI]
78. "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" (2021)[URL]
79. "Laboratory biosafety guidance related to coronavirus disease (COVID-19): interim guidance, 28 January 2021" (2021)[URL]
80. Kaufer AM, "Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent", Pathology, 52, pp.790~795 (2020)
81. Bloise I, "Detection of SARS-CoV-2 on high-touch surfaces in a clinical microbiology laboratory", J Hosp Infect, 105, pp.784~786 (2020)
82. Zuckerman NS, "Comprehensive analyses of SARS-CoV-2 transmission in a public health virology laboratory", Viruses, 12, pp.854~ (2020)

관련 논문AI추천